Cited by 1,222Liver Disease Diagnosis and TreatmentLiver Diseases and ImmunityDrug-Induced Hepatotoxicity and Protection

ACG clinical guideline: evaluation of abnormal liver chemistries

Kwo, Paul Y, Cohen, Stanley M, Lim, Joseph K·2017·American Journal of Gastroenterology

Abstract

Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests should be termed liver chemistries or liver tests. Hepatocellular injury is defined as disproportionate elevation of AST and ALT levels compared with alkaline phosphatase levels. Cholestatic injury is defined as disproportionate elevation of alkaline phosphatase level as compared with AST and ALT levels. The majority of bilirubin circulates as unconjugated bilirubin and an elevated conjugated bilirubin implies hepatocellular disease or cholestasis. Multiple studies have demonstrated that the presence of an elevated ALT has been associated with increased liver-related mortality. A true healthy normal ALT level ranges from 29 to 33 IU/l for males, 19 to 25 IU/l for females and levels above this should be assessed. The degree of elevation of ALT and or AST in the clinical setting helps guide the evaluation. The evaluation of hepatocellular injury includes testing for viral hepatitis A, B, and C, assessment for nonalcoholic fatty liver disease and alcoholic liver disease, screening for hereditary hemochromatosis, autoimmune hepatitis, Wilson's disease, and alpha-1 antitrypsin deficiency. In addition, a history of prescribed and over-the-counter medicines should be sought. For the evaluation of an alkaline phosphatase elevation determined to be of hepatic origin, testing for primary biliary cholangitis and primary sclerosing cholangitis should be undertaken. Total bilirubin elevation can occur in either cholestatic or hepatocellular diseases. Elevated total serum bilirubin levels should be fractionated to direct and indirect bilirubin fractions and an elevated serum conjugated bilirubin implies hepatocellular disease or biliary obstruction in most settings. A liver biopsy may be considered when serologic testing and imaging fails to elucidate a diagnosis, to stage a condition, or when multiple diagnoses are possible.

Integrity signals

Registry

Crossref · 10.1038/ajg.2016.517

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kwo, P. Y., Cohen, S. M., & Lim, J. K.
Affiliations
  • Stanford Medicine (US)
  • University Hospitals of Cleveland (US)
  • Yale University (US)
Corresponding author
Kwo, Paul Y
Venue
American Journal of Gastroenterology
Published
2017-01
Volume
112
Issue
1
Pages
18-35
ISSN
0002-9270 (ISSN-L)
OpenAlex
W2563118732
Cited by
1,222
References
98
Citations by year
2026: 161 · 2025: 159 · 2024: 176 · 2023: 158 · 2022: 144 · 2021: 141 · 2020: 116 · 2019: 81 · 2018: 62 · 2017: 18 · 2016: 1 · 2014: 1 · 2012: 1
FWCI
50.65
Type
journal article
Language
en
Open access
closed
Locations
  • The American Journal of Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, bilirubin, hepatocyte injury, cholestatic liver injury, viral hepatitis screening, non-alcoholic fatty liver disease, alcoholic liver disease, hereditary hemochromatosis, autoimmune hepatitis, Wilson's disease, alpha-1 antitrypsin deficiency, primary biliary cirrhosis, primary sclerosing cholangitis, liver biopsy, liver-related mortality
MeSH terms
Alanine Transaminase, Alkaline Phosphatase, Aspartate Aminotransferases, Bilirubin, Biopsy, Cholestasis, Hemochromatosis, Hepatitis, Viral, Human, Hepatolenticular Degeneration, Humans, Liver, Liver Diseases, Liver Diseases, Alcoholic, Hepatitis, Autoimmune, alpha 1-Antitrypsin Deficiency, Chemical and Drug Induced Liver Injury, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review